INSIGHT GENETICS, INC.

Basic Information

111 10th Ave. South Suite 110
NASHVILLE, TN, 37203-

Company Profile

n/a

Additional Details

Field Value
DUNS: 190114962
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 20


  1. TOPIC 277 PHASE II; COMPANION DIAG: PREDICTIVE AND PROGNOSTIC TEST ENABLING PERSO

    Amount: $1,499,990.00

    Not Available

    SBIR Phase II 2013 Department of Health and Human Services
  2. OTHER FUNCTIONS DEVELOPMENT OF A COMPANION DIAGNOSTIC FOR ALK MUTATIONS.

    Amount: $1,495,220.00

    Constitutively activated forms of ALK caused by genetic aberrations have been shown to cause an expanding variety of human cancers. The FDA recently approved the Pfizer drug Xalkori (crizotinib) to t ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. IGF::OT::IGF OTHER FUNCTIONS- RandD BIOMEDICAL (BASIC RESEARCH)

    Amount: $199,576.00

    Lung cancer is the main cause of cancer mortality worldwide with 80% non-small cell lung cancer (NSCLC) in type and mainly driven by three mutually exclusive oncogenes, EGFR, KRAS and ALK (collectivel ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Companion Diagnostic for ALK Mutations

    Amount: $200,000.00

    Kinase inhibitors such as Gleevec and Tarceva have markedly improved cancer therapy. Essential to the use of such inhibitors are companion diagnostics enabling determination of the mutational status o ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government